MS4A1 and myeloid sarcoma: Rituximab is also being used in other autoimmune diseases, including rheumatoid arthritis (RA) [56], multiple sclerosis (MS) [57], and neuromyelitis optica (NMO) [58], showing the significance of targeting MS4A1 and B cells.